A detailed history of Stifel Financial Corp transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Stifel Financial Corp holds 285,491 shares of DVAX stock, worth $3.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
285,491
Previous 290,226 1.63%
Holding current value
$3.64 Million
Previous $3.26 Million 2.42%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.05 - $11.61 $47,586 - $54,973
-4,735 Reduced 1.63%
285,491 $3.18 Million
Q2 2024

Aug 13, 2024

SELL
$10.73 - $12.58 $24,957 - $29,261
-2,326 Reduced 0.8%
290,226 $3.26 Million
Q1 2024

May 13, 2024

SELL
$11.7 - $14.98 $36,223 - $46,378
-3,096 Reduced 1.05%
292,552 $3.63 Million
Q4 2023

Feb 12, 2024

SELL
$13.09 - $14.98 $71,379 - $81,685
-5,453 Reduced 1.81%
295,648 $4.13 Million
Q3 2023

Nov 13, 2023

BUY
$12.64 - $14.99 $28,288 - $33,547
2,238 Added 0.75%
301,101 $4.45 Million
Q2 2023

Aug 14, 2023

SELL
$9.85 - $13.17 $29,658 - $39,654
-3,011 Reduced 1.0%
298,863 $3.86 Million
Q1 2023

May 12, 2023

BUY
$9.44 - $11.88 $113,006 - $142,215
11,971 Added 4.13%
301,874 $2.96 Million
Q4 2022

Feb 13, 2023

SELL
$10.27 - $13.29 $6,172 - $7,987
-601 Reduced 0.21%
289,903 $3.08 Million
Q3 2022

Nov 14, 2022

SELL
$9.93 - $17.44 $122,744 - $215,575
-12,361 Reduced 4.08%
290,504 $3.03 Million
Q2 2022

Aug 15, 2022

SELL
$7.45 - $12.83 $72,779 - $125,336
-9,769 Reduced 3.12%
302,865 $3.81 Million
Q1 2022

May 13, 2022

SELL
$9.75 - $14.44 $141,375 - $209,380
-14,500 Reduced 4.43%
312,634 $3.39 Million
Q4 2021

Feb 14, 2022

BUY
$13.17 - $20.94 $184,669 - $293,620
14,022 Added 4.48%
327,134 $4.6 Million
Q3 2021

Nov 15, 2021

BUY
$9.16 - $19.83 $1.19 Million - $2.57 Million
129,664 Added 70.68%
313,112 $6.02 Million
Q2 2021

Aug 13, 2021

BUY
$7.25 - $10.99 $3,857 - $5,846
532 Added 0.29%
183,448 $1.81 Million
Q1 2021

May 14, 2021

BUY
$4.57 - $11.18 $835,926 - $2.05 Million
182,916 New
182,916 $1.8 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.